Aquinox Pharmaceuticals: Aquinox Pharmaceuticals Announces Second Quarter 2018 Financial Results

(marketscreener.com) VANCOUVER, British Columbia, Aug. 08, 2018 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. ("Aquinox") (NASDAQ:AQXP), a pharmaceutical company discovering and developing novel drug candidates to treat inflammation, inflammatory pain, and blood cancers, today provided a corporate update and reported financial results for the second quarter...http://www.marketscreener.com/AQUINOX-PHARMACEUTICALS-I-15946471/news/Aquinox-Pharmaceuticals-Announces-Second-Quarter-2018-Financial-Results-27077132/?utm_medium=RSS&utm_content=20180808